InDex Pharmaceuticals is funded by high-quality venture investors including Industrifonden, SEB Venture Capital and NeoMed Management.
Industrifonden invests in small and medium-sized Swedish companies with international growth potential. Value is created by working closely and actively with the companies. All investments are based on commercial terms with entrepreneurs and other investors.
SEB Venture Capital
SEB is one of the most highly regarded companies in the Nordic venture capital sector. SEB invests in unlisted companies with growth potential and healthy chances of international expansion. These operations also need to have a long-term, sustainable competitive edge and be managed by people with the requisite entrepreneurial drive and experience.
NeoMed Management is an international venture capital investment firm exclusively focused on the
healthcare industry. Founded in 1997, NeoMed has established five funds to date. NeoMed invests
in emerging companies with outstanding growth prospects. These companies are developing
innovative and proprietary medical products that address substantial market opportunities in the
pharmaceutical, medical device and diagnostics industries.